These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36008001)

  • 1. Precision diagnostics in cancer: Predict, prevent, and personalize.
    Crabtree JS; Miele L
    Prog Mol Biol Transl Sci; 2022; 190(1):39-56. PubMed ID: 36008001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.
    Jobanputra V; Wrzeszczynski KO; Buttner R; Caldas C; Cuppen E; Grimmond S; Haferlach T; Mullighan C; Schuh A; Elemento O
    Semin Cancer Biol; 2022 Sep; 84():23-31. PubMed ID: 34256129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
    Surrey LF; Luo M; Chang F; Li MM
    Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development.
    Yap TA; Stadler ZK; Stout LA; Schneider BP
    Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390738. PubMed ID: 37390373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics.
    Doig KD; Love CG; Conway T; Seleznev A; Ma D; Fellowes A; Blombery P; Fox SB
    BMC Med Genomics; 2022 Mar; 15(1):70. PubMed ID: 35346197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Status and Impact of Clinical Tumor Genome Sequencing.
    Shaw KRM; Maitra A
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():413-432. PubMed ID: 30995147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline contamination and leakage in whole genome somatic single nucleotide variant detection.
    Sendorek DH; Caloian C; Ellrott K; Bare JC; Yamaguchi TN; Ewing AD; Houlahan KE; Norman TC; Margolin AA; Stuart JM; Boutros PC
    BMC Bioinformatics; 2018 Jan; 19(1):28. PubMed ID: 29385983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Copy Number Alterations from Next-Generation Sequencing Data.
    Nabavi S; Zare F
    Adv Exp Med Biol; 2022; 1361():55-74. PubMed ID: 35230683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of cancer next-generation sequencing testing in a community hospital.
    Akkari Y; Smith T; Westfall J; Lupo S
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer.
    Armstrong AJ; Li X; Tucker M; Li S; Mu XJ; Eng KW; Sboner A; Rubin M; Gerstein M
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):786-793. PubMed ID: 33568750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.